Abstract Submission

The Organizing Committee invites you to submit an abstract of your scientific research to be considered for presentation during the Symposium poster session. The deadline for submission is July 30, 2009. Notice of acceptance will be sent to authors by August 14, 2009.


Preparation/Formating Guidelines

  • Abstracts should be single-spaced and contain a maximum of 300 words.
  • Submissions should be in Word, using 12 point Arial or similar font, with 1.5"
    margins (left, right, bottom, top).
  • The following information must appear at the top: Abstract title, names, and
    affiliations of authors with the name of presenter in bold.

    Example:

    John Doe1, Mary Smith2, Peter Jones3.
    1National Cancer Institute, 2Channing Laboratory, Harvard University and
    3University of California, San Francisco.

  • Abstracts should provide clear data and validated conclusions. They should
    consist of an introduction that presents the background of the study, a brief
    description of the methods employed, a summary of the results, and a
    statement of the conclusions.



Submission Guidelines

Please submit your abstract through the registration website no later than July 30, 2009. In the subject line, put "Abstract - Submitter's Name." A confirmation reply will be sent to you in August.

In the body of your email, please include:

  • Name and degree(s)
  • Position Titile, Department, Affiliation
  • Mailing Address
  • Telephone, Fax, Email

If you have any problems with email submission, please contact Rosa Hugo at 301-435-9284 or via email at hugor@nhlbi.nih.gov.

symposium goals

  - To provide an overview of the
    NHLBI roadmap for cardio-
    vascular stem cell research
    going forward.

  - To relate novel insights from
    embryonic cardiovascular
    development to our understand-
    ing of adult cardiovascular
    stem cells.

 - To review the recent break-
    through discovery of induced-
    pluripotent stem cells (iPS-cells),
    and how they might be harness-
    ed for therapeutic applications.

 - To discuss the emerging and
    inter-related field of epithelial
    to mesenchymal transition,
    and the relevance of this to
    cardiovascular and stem cell
    biology.

 - To emphasize recent discover-
    ies that will facilitate the trans-
    lation of this knowledge from
    bench to bedside.
Twitter iconTwitterExternal link Disclaimer         Facebook iconFacebookimage of external link icon         YouTube iconYouTubeimage of external link icon         Google+ iconGoogle+image of external link icon